共 50 条
- [22] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH BETTER SURVIVAL OUTCOMES FOR METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB PLUS IPILIMUMAB JOURNAL OF UROLOGY, 2022, 207 (05): : E175 - E175
- [24] A CASE OF A NEUROLOGICAL IMMUNE-RELATED ADVERSE EVENT ASSOCIATED WITH IPILIMUMAB/NIVOLUMAB JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
- [28] Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab ONCOLOGY-NEW YORK, 2020, 34 (05): : 171 - 174